Epigenetic Regulation of Epithelial to Mesenchymal Transition

Author(s): Peiwei Huangyang, Yongfeng Shang

Journal Name: Current Cancer Drug Targets

Volume 13 , Issue 9 , 2013

Become EABM
Become Reviewer
Call for Editor


Epithelial-mesenchymal transition (EMT) is a vital process implemented in embryo development, organ fibrosis, and cancer metastasis. Several transcription factors and signaling pathways impinge on the transcriptional program of the cell, leading to the change of cell phenotype without alteration of genotype. Accumulating evidence suggests that epigenetic mechanisms play important roles in inducing EMT and orchestrating the heredity and reversibility of EMT. In this review, we discuss how DNA methylation, histone modifications, and microRNAs (miRNAs) act in a concerted manner to regulate EMT. ‘Epigenetic therapies’—inhibitors of DNA methyltransferases and histone deacetylases as well as microRNAs are emerging as promising agents for cancer intervention.

Keywords: DNMT inhibitors, EMT, epigenetic regulation, epigenetic therapy, HDAC inhibitors, metastasis, miRNAs.

Rights & PermissionsPrintExport Cite as

Article Details

Year: 2013
Published on: 12 December, 2013
Page: [973 - 985]
Pages: 13
DOI: 10.2174/15680096113136660103
Price: $65

Article Metrics

PDF: 48